Tyra Bioscience (TYRA) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Tyra Bioscience (TYRA) Company Statistics | The Fly

Tyra Bioscience

· TYRA

Dashboard

Financials

Ratios

Valuation

Statistics

1.511 B

-0.50%

General

Market Cap: $1.51B
Enterprise Value: $1.24B
Shares Outstanding: 59,470,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -38.75%
ROE: -46.39%
ROIC: -44.78%
Current Ratio: 14.91
Debt-to-Equity: 0.02
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.27
P/S: —
P/FCF: —
P/B: 3.69
EV/EBITDA: -8.35

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $160.32M
Operating Income: -$160.46M
Net Profit: -$148.57M

Balance Sheet

Cash and Equivalents: $73.84M
Working Capital: $342.35M
Total Assets: $383.36M
Net Debt: -$68.25M
Total Liabilities: $29.7M
Total Equity: $353.66M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$109.65M
Cash Flow from Investing: -$82.82M
Cash Flow from Financing: $167.82M
Free Cash Flow: -$109.9M
Capital Expenditures: $250K